“…However, there is an intrinsic limitation to the formation of the stable triplex DNA against the target duplex DNA sequence under physiological conditions. We have been studying the design and synthesis of the artificial nucleoside analogues for the recognition of the TA or CG inversion sites with a high selectivity and stability (Okamura, Taniguchi, & Sasaki, 2013, 2014. Recently, we found and reported that the TFOs containing novel C-nucleoside analogues, i.e., the 2 -deoxy-4-aminopyridinylpseudocytidine derivatives, formed the stable triplex DNA containing the CG inversion site with a high selectivity (Okamura, Taniguchi, & Sasaki, 2016;Wang, Taniguchi, Okamura, & Sasaki, 2017, 2018.…”